Takeda sales and marketing update

Takeda and its Takeda Pharmaceuticals North America Inc. subsidiary launched 40 and 80 mg Edarbi azilsartan medoxomil in the U.S. to treat hypertension. The wholesale acquisition price is $75 per bot...